Weight loss, exercise, and metformin for knee osteoarthritis in overweight adults
Official title: Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity, a Randomized Controlled Trial
Run by The University of Hong Kong · NCT07065591 · Data updated 2026-11-12
This study tests whether adding metformin to diet and exercise can reduce knee pain and body weight in adults with overweight or obesity and knee osteoarthritis who are considering knee replacement.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Sandy Bay) |
| Status | Recruiting |
| Started | August 30, 2026 |
| Main results expected | April 17, 2028 |
| Study ends | July 17, 2028 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07065591 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–80 with knee OA, BMI ≥23 kg/m2, knee pain for at least 6 months, and considering joint replacement.
✕Probably not a fit
Those with advanced knee OA or contraindications to metformin may are less likely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This early-phase study investigates whether a combined lifestyle program of diet modification and structured exercise, with the addition of metformin, can improve knee OA symptoms and reduce weight in overweight or obese adults. Participants are adults 40–80 with knee OA, persistent knee pain, and BMI in the overweight/obese range, and they are candidates for knee replacement consideration. The trial compares metformin to placebo as an adjunct to lifestyle interventions. Primary outcomes focus on changes in pain and body weight, with secondary outcomes including functional measures and potential impact on future knee replacement needs. The study is conducted at a single Hong Kong site under the University of Hong Kong.
Why it matters
Potential benefit: If successful, participants may experience reduced knee pain and body weight, potentially slowing OA progression and delaying the need for knee replacement.
How similar studies have gone: Previous weight-management and lifestyle approaches have shown pain reduction in KOA, with metformin being explored for weight control and metabolic benefits in OA contexts; this combination is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women age between 40 and 80 years old, with overweight or obesity (body mass index ≥23 kg/m2) according to Hong Kong Centre for Health Protection definition of overweight and obesity. * Knee pain for 6+ months with Visual Analogue Scale (VAS) \> 40mm/100mm and * Meet the American College of Rheumatology criteria for knee OA * OA referred for consideration for joint replacement Exclusion Criteria: * Severe radiographic knee OA (Kellgren-Lawrence grade 4) or severe knee pain (VAS\>80mm/100 mm) that could not tolerate further conservative management; * inflammatory arthritis like rheumatoid arthritis, crystal arthritis, etc. * Preexisting diabetes on antidiabetic drug or drug allergy to metformin. * Recent knee surgery of the same knee * Significant bone loss. * Concomitant neuromuscular diseases affecting lower limb function. * renal or liver impairment precluding use of metformin. * VitaminB12 deficiency
Where it's running
-
Maclehose Medical Rehabilitation
Hong Kong, Sandy Bay, Hong Kong Recruiting
Study contacts
- Study coordinator: Lawrence Lau, FRCS, PhD
- Email: laucml@hku.hk
- Phone: +852 92646862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial knee osteoarthritis: inside vs outside corticosteroid injection
This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.
-
Platelet-rich plasma added to hyaluronic acid for knee osteoarthritis
This study tests whether a single injection of hyaluronic acid plus autologous platelet-rich plasma helps reduce knee OA symptoms more than hyaluronic acid alone in adults with moderate knee OA.
-
Hyaluronic Acid Plus PRP Injection for Knee Osteoarthritis
This study tests whether a single HA injection combined with a patient’s own PRP is better at easing knee OA pain than HA alone.
-
Long-acting local pain medicine after knee replacement
This study tests whether a new extended-release pain medicine (Zynrelef) given around the knee during total knee replacement can reduce pain after surgery better or as well as standard injections or nerve blocks.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Modular powered knee braces to help move better and reduce knee pain
A device with partial motor support is being tested in adults with knee OA to see if it can ease pain and reduce effort during daily activities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.